|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?|
|Jong Eun Yeon|
|Clin Mol Hepatol. 2018;24(3):294-296. Published online 2018 September 11 DOI: https://doi.org/10.3350/cmh.2018.1009|
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
Comparison of Sofosbuvir Plus Ribavirin Plus Peg-Interferon With Sofosbuvir and Ribavirin for Treatment of Genotype 3 Treatment Naive Indian Chronic Hepatitis C Patients: An Interim Analysis of Ongoing RCT
Dual Treatment With Sofosbuvir Plus Ribavirin is as Effective as Triple Therapy With Pegylated Interferon Plus Sofosbuvir Plus Ribavirin in Predominant Genotype 3 Patients With Chronic Hepatitis C
Su1452 Treatment of Chronic Hepatitis C Genotype 2 With Simeprivir Plus Sofosbuvir With or Without Ribavirin in Veterans With and Without Cirrhosis
Sofosbuvir plus ribavirin in Asian patients with chronic genotype 2 hepatitis C virus infection: history of a success?
Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C
Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
P1-092: The efficacy of sofosbuvir/velpatasvir/ribavirin in cirrhotic, genotype 3a HCV patients, previously failures to sofosbuvir/daclatasvir/ribavirin combination
Does Ribavirin Still Have a Role in Sofosbuvir and Velpatasvir Therapy for Patients With HCV Genotype 3 Infection and Cirrhosis?
P1218 STEATOSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 3 DOESN'T AFFECT THE OUTCOME OF PEGINTERFERON ALPHA-2a PLUS RIBAVIRIN TREATMENT
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|